BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6258175)

  • 1. Coxsackie B3 myocarditis in athymic mice.
    Robinson JA; O'Connell JB; Roeges LM; Major EO; Gunnar RM
    Proc Soc Exp Biol Med; 1981 Jan; 166(1):80-91. PubMed ID: 6258175
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of T lymphocytes in the pathogenesis of Coxsackie virus B3 heart disease.
    Hashimoto I; Tatsumi M; Nakagawa M
    Br J Exp Pathol; 1983 Oct; 64(5):497-504. PubMed ID: 6315043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell-mediated immune response enhances the severity of myocarditis in secondary cardiotropic virus infection in mice.
    Kishimoto C; Hiraoka Y; Takada H
    Basic Res Cardiol; 2001 Sep; 96(5):439-45. PubMed ID: 11605990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological mechanisms in experimental coxsackievirus B3 myocarditis in mice.
    Kishimoto C; Ochiai H; Sasayama S
    Jpn Circ J; 1991 Nov; 55(11):1144-8. PubMed ID: 1721094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular matrix remodeling in coxsackievirus B3 myocarditis.
    Kishimoto C; Kitazawa M; Hiraoka Y; Takada H
    Clin Immunol Immunopathol; 1997 Oct; 85(1):47-55. PubMed ID: 9325069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coxsackievirus B3 persistence and myocarditis in NFR nu/nu and +/nu mice.
    Schnurr DP; Schmidt NJ
    Med Microbiol Immunol; 1984; 173(1):1-7. PubMed ID: 6088960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo significance of T cells in the development of Coxsackievirus B3 myocarditis in mice. Immature but antigen-specific T cells aggravate cardiac injury.
    Kishimoto C; Abelmann WH
    Circ Res; 1990 Sep; 67(3):589-98. PubMed ID: 1697791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of sex hormones on Coxsackie B-3 virus infection in Balb/c mice.
    Huber SA; Job LP; Auld KR
    Cell Immunol; 1982 Feb; 67(1):173-9. PubMed ID: 6280880
    [No Abstract]   [Full Text] [Related]  

  • 9. Coxsackievirus B3 persistence and myocarditis in N:NIH(S) II nu/nu and +/nu mice.
    Schnurr DP; Cao Y; Schmidt NJ
    J Gen Virol; 1984 Jul; 65 ( Pt 7)():1197-201. PubMed ID: 6747601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elution of autoantibodies from the hearts of coxsackievirus-infected mice.
    Neumann DA; Lane JR; LaFond-Walker A; Allen GS; Frondoza C; Herskowitz A; Rose NR
    Eur Heart J; 1991 Aug; 12 Suppl D():113-6. PubMed ID: 1655441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coxsackievirus-B3-induced myocarditis: virus receptor antibodies modulate myocarditis.
    Kennedy JR
    J Immunol; 1990 Mar; 144(6):2446-7. PubMed ID: 2155966
    [No Abstract]   [Full Text] [Related]  

  • 12. Cellular immune mechanisms in Coxsackievirus group B, type 3 induced myocarditis in Balb/C mice.
    Huber SA; Job LP
    Adv Exp Med Biol; 1983; 161():491-508. PubMed ID: 6307010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of T cells in coxsackievirus B-induced disease.
    Schwimmbeck PL; Huber SA; Schultheiss HP
    Curr Top Microbiol Immunol; 1997; 223():283-303. PubMed ID: 9294934
    [No Abstract]   [Full Text] [Related]  

  • 14. Cytokine and murine coxsackievirus B3 myocarditis. Interleukin-2 suppressed myocarditis in the acute stage but enhanced the condition in the subsequent stage.
    Kishimoto C; Kuroki Y; Hiraoka Y; Ochiai H; Kurokawa M; Sasayama S
    Circulation; 1994 Jun; 89(6):2836-42. PubMed ID: 8205699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of coxsackievirus B3 myocarditis in mice by lobenzarit disodium through inhibition of splenic pan T cells.
    Kishimoto C; Takada H; Kuroki Y; Matsushita I; Hiraoka Y; Kurokawa M; Ochiai H; Sasayama S
    Cardiovasc Res; 1993 Feb; 27(2):243-8. PubMed ID: 8386064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetics of Coxsackie B3 (CVB3) myocarditis.
    Van Houten N; Huber SA
    Eur Heart J; 1991 Aug; 12 Suppl D():108-12. PubMed ID: 1655440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmentation of pathogenesis of coxsackievirus B3 infections in mice by exogenous administration of interleukin-1 and interleukin-2.
    Huber SA; Polgar J; Schultheiss P; Schwimmbeck P
    J Virol; 1994 Jan; 68(1):195-206. PubMed ID: 8254729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac injury in myocarditis induced by Coxsackievirus group B, type 3 in Balb/c mice is mediated by Lyt 2 + cytolytic lymphocytes.
    Guthrie M; Lodge PA; Huber SA
    Cell Immunol; 1984 Oct; 88(2):558-67. PubMed ID: 6091924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac myosin-induced myocarditis as a model of postinfectious autoimmunity.
    Neu N; Klieber R; Frühwirth M; Berger P
    Eur Heart J; 1991 Aug; 12 Suppl D():117-20. PubMed ID: 1655442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of experimental murine Coxsackie B3 myocarditis.
    Herzum M; Huber SA; Weller R; Grebe R; Maisch B
    Eur Heart J; 1991 Aug; 12 Suppl D():200-2. PubMed ID: 1655448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.